Breaks Categories: News

MondayJul 08, 2019 10:08 am

NetworkNewsBreaks – Imaging3 Inc./Grapefruit Boulevard Investments Inc. (IGNG) Executes Settlement Agreement with Greenberg Glusker

Imaging3 Inc./Grapefruit Boulevard Investments Inc. (OTCQB: IGNG) today announced that it has reached a settlement agreement with its former bankruptcy counsel and largest trade creditor, Greenberg Glusker Fields Claman & Machtinger LLP (“GG”). Per the update, the agreement calls for IGNG/Grapefruit to liquidate the outstanding $1,245,380 balance through payment of $204,000 to GG in three $68,000 installments by November 30, 2019, as well as immediate issuance of 6,351,126 IGNG common shares to GG at an agreed value of $0.164 per share. “Once again we have achieved a positive conclusion to a significantly thorny component of Grapefruit’s reverse acquisition of IGNG.…

Continue Reading

MondayJul 08, 2019 9:45 am

NetworkNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Enters Definitive Agreement to Acquire The GoodFellas Group LLC

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) this morning announced its entry into a definitive acquisition agreement dated July 6, 2019, to acquire The Goodfellas Group LLC, a company specializing in branding, sales and marketing in the cannabis and hemp industries. According to the update, the acquisition includes the GoodFellas sales management team and sales force, as well as its existing inhouse brands, Simple Farms and Daily Cannabis Goods. Goodfellas also represents third party cannabis brands, including Biovelle, a CBC-infused coconut oil that TransCanna proposes to acquire. "As represented in our investor conference call last week we've accomplished the first…

Continue Reading

FridayJul 05, 2019 11:57 am

NetworkNewsBreaks – Fortune Business Insights Issues Detailed Research Report on the Push-to-Talk Industry

Fortune Business Insights, a provider of meticulous analysis with a specialized focus on accuracy of data obtained, recently published a report including a market forecast, analysis and insight on the global push-to-talk (“PTT”) market. As technology continues to advance, PTT solutions are transforming to be more efficient. Through the deployment of enhanced internet services, major telecommunications companies such as AT&T Inc. (NYSE: T), Motorola Solutions Inc. (NYSE: MSI) and Sprint Corporation (NYSE: S) are working to deliver prompt and accurate voice processing systems. According to the report, AT&T intends to develop new PTT devices for mission-critical push-to-talk (“MCPTT”) that reach…

Continue Reading

FridayJul 05, 2019 10:39 am

NetworkNewsBreaks – ROTH Capital Partners to Host RNA Revolution Conference in New York City

Full-service investment bank ROTH Capital Partners recently announced that it will host its RNA Revolution Conference at the 1 Hotel Central Park in New York City on Wednesday, July 17, 2019. According to the update, the invitation-only event for ROTH institutional clients will provide investors the opportunity to deep dive into scientific discussions about differences between various RNA modalities (mRNA, ASO, siRNA, and RNA-targeted small molecule), drug delivery nuances, and improvements to these drugs to make them more effective and safer. Co-Head of Biotechnology Research and Senior Research Analyst Yasmeen Rahimi, Ph.D. will moderate four panel discussions addressing topics on…

Continue Reading

FridayJul 05, 2019 10:11 am

NetworkNewsBreaks – ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) Closes $15.6M Underwritten Public Offering

ContraVir Pharmaceuticals (NASDAQ: CTRV), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis (“NASH”) and chronic viral infection, has closed an underwritten public offering resulting in total gross proceeds of approximately $15.6 million. According to the update, the offered securities included (i) Class A units, at a combined price of $6.00 per unit, each consisting of one share of common stock and one warrant to purchase one share of common stock, and (ii) Class B units, at a combined price of $1,000 per unit, each consisting of one share…

Continue Reading

FridayJul 05, 2019 9:39 am

NetworkNewsBreaks – Akero Therapeutics, Inc. (NASDAQ: AKRO) Closes $105.8 Million IPO

Akero Therapeutics (NASDAQ: AKRO), a clinical-stage biotechnology company developing transformational treatments for people with non-alcoholic steatohepatitis (“NASH”) and other serious metabolic disorders, has closed its initial public offering, resulting in gross proceeds of approximately $105.8 million. The offering of 6,612,500 shares included 862,500 additional shares per the full exercise of the over-allotment option granted to the underwriters. The shares, sold each at the public offering price of $16.00, began trading on the Nasdaq Global Select Market on June 20, 2019 under the ticker symbol "AKRO." ROTH Capital Partners acted as lead manager for the offering. To view the full press…

Continue Reading

FridayJul 05, 2019 9:19 am

NetworkNewsBreaks – ArQule, Inc. (NASDAQ: ARQL) Closes $103.7M Follow-On

ArQule (NASDAQ: ARQL), a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and rare diseases, recently closed its underwritten public offering of 10,637,500 shares of common stock, which includes 1,387,500 shares representing the over-allotment option that the underwriters fully exercised. With shares sold at the public offering price of $9.75 each, the offering resulted in gross proceeds of roughly $103.7 million. The company plans to use the proceeds toward its clinical programs and for general corporate purposes. ROTH Capital Partners acted as co-manager for the offering. To view the full press release, visit http://nnw.fm/kFr9H…

Continue Reading

WednesdayJul 03, 2019 12:25 pm

NetworkNewsBreaks – Fortune Business Insights Provides Detailed Analysis on the Offshore Wind Power Industry

Fortune Business Insights, a provider of meticulous analysis with a specialized focus on accuracy of data obtained, recently published a report including a market forecast, analysis and insight on the global offshore wind power market. As economic demands and popularity increase in offshore wind power the United Kingdom and China are expected to lead the global market, with the demand of energy consumption increasing and resources continue to decrease in the forecasted reporting years. In terms of water depth, shallow levels under 30 meters (“M”) are currently leading in the market due to the ease of technological access. While current…

Continue Reading

WednesdayJul 03, 2019 11:10 am

NetworkNewsBreaks – Wuhan General Group (China) Inc. (WUHN) Issues Update on Third Quarter Corporate Highlights

Wuhan General Group (China) Inc. (OTC: WUHN) on Tuesday issued a statement to shareholders and provided a list of its corporate milestones. In the update, the company clarified that Wuhan General Group is a U.S.-registered corporation and has no dealings with any Chinese parties relating to its ongoing business activities. The company has retained the services of a law firm in order to take all necessary steps to file a name change with FINRA to remove any possible confusion with its current name and to better reflect the nature of the business. In addition, the company announced that it is…

Continue Reading

WednesdayJul 03, 2019 10:59 am

NetworkNewsBreaks – INmune Bio Inc. (NASDAQ: INMB) Co-Founder and CEO Showcases XPro1595 at Maxim Group’s Conference on Alzheimer’s Disease

INmune Bio Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, this morning announced that its co-founder and CEO, R.J. Tesi, M.D., presented at the Maxim Group’s conference on Alzheimer’s disease on June 26 in New York. According to the update, Tesi’s presentation addressed how INmune Bio’s XPro1595 drug candidate targets microglial activation and neuroinflammation to treat Alzheimer’s, which may be a key driver in the disease. “I was delighted to showcase INmune Bio’s development program with XPro1595 in Alzheimer’s disease,” Tesi said in the news release. “We believe…

Continue Reading